TYRA
Tyra Biosciences, Inc.
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Last report0 of 8 at or beyond impliedshaded = implied▲▼ = realized× = |realized| ÷ implied
Fund move
Fund move
Largest filed tie
0
filed ties
−20.97%
vs ±26.7% implied · ×0.78
shaded = implied · ▲▼ = realized
No thesis.
| Rank | Manager | Value | % 13F | ||
|---|---|---|---|---|---|
| 1 | RA Capital ManagementRA Capital Management | $389.6M | 17.47% | 0.00% | |
| 2 | FMRFMR | $284.9M | 12.77% | +15.14% | |
| 3 | Jupiter TopcoJupiter Topco | $139.2M | 6.24% | — | |
| 4 | Alta Partners ManagementAlta Partners | $122.1M | 5.48% | 0.00% | |
| 5 | Nextech InvestNextech Invest | $113.5M | 5.09% | −12.38% | |
| 6 | TCG Crossover ManagementTCG Crossover | $103.8M | 4.65% | 0.00% | |
| 7 | BlackRockBlackRockindex-like | $96.8M | 4.34% | +36.70% | |
| 8 | T. Rowe Price AssociatesT. Rowe Price | $88.9M | 3.98% | +182.19% | |
| 9 | State StreetState Streetindex-like | $68.4M | 3.07% | +76.01% | |
| 10 | Commodore CapitalCommodore Capital | $59.9M | 2.69% | −24.24% | |
| 11 | Paradigm Biocapital AdvisorsParadigm Biocapital | $58.4M | 2.62% | −11.02% | |
| 12 | Vanguard Capital ManagementVanguardindex-like | $48.2M | 2.16% | +33.97% | |
| 13 | BVFBVF | $47.1M | 2.11% | −25.30% | |
| 14 | 5AM Venture Management5AM Venture | $32.9M | 1.47% | 0.00% | |
| 15 | Deerfield ManagementDeerfield | $32.5M | 1.46% | +85.25% | |
| 16 | Hood River Capital ManagementHood River | $32.5M | 1.46% | new | |
| 17 | Geode Capital ManagementGeodeindex-like | $31.0M | 1.39% | +47.42% | |
| 18 | Caligan PartnersCaligan Partners | $25.8M | 1.16% | −36.80% | |
| 19 | Canaan Partners XICanaan Partners XI | $24.0M | 1.07% | 0.00% | |
| 20 | SirenSiren | $23.2M | 1.04% | new | |
| 21 | Sio Capital ManagementSio | $22.2M | 1.00% | +14.84% | |
| 22 | StemPoint CapitalStemPoint Capital | $20.2M | 0.91% | +115.83% | |
| 23 | Marshall WaceMarshall Wace | $18.6M | 0.84% | +194.89% | |
| 24 | Goldman Sachs GroupGoldman Sachs | $14.8M | 0.66% | −15.78% | |
| 25 | Jennison AssociatesJennison | $14.4M | 0.65% | −28.69% |
170 managers report $2.2B of Tyra Biosciences on form 13F for the quarter ended Jun 30 '26. 19 of them hold 80% of it; RA Capital Management is largest at 17.47%.
Tyra Biosciences, Inc.
21.35
+0.02 · +0.09%
post 21.35 0.00%
Expected move
Inputs8Q avg ±4.7%·×2.78·rich
straddle ±16.1%
spot 21.37exp Nov 20ATM strike 22.5ATM straddle 4.05IV 105%